Diagnostic breast screening: clinical significance during menopause.
Three-hundred and fifty nine out-patients with no signs of breast disease, who had been seen at the Gynecology and Obstetrics Clinic for problems related to their perimenopausal state, were also screened at the Breast Pathology Center to exclude the presence of hormone-sensitive neoplastic disease, in view of possible hormone therapy. The breast cancer incidence detected (1.7%), and the importance of thermography in evaluating the metabolic-functional aspects of the breast, confirm the utility of breast screening in all perimenopausal patients.